Divyanee Garg | Economics, Econometrics and Finance | Best Researcher Award

Ms. Divyanee Garg | Economics, Econometrics and Finance | Best Researcher Award

Indian Institute of Technology, Delhi | India

Ms. Divyanee Garg is a mathematician specializing in Portfolio Optimization, Behavioural Finance, Robust Portfolio Optimization, and Data-Driven Financial Techniques. Her research focuses on developing innovative mathematical and computational frameworks for decision-making under uncertainty, combining advanced risk measures such as Expectile Value at Risk (EVaR) and Conditional Value at Risk (CVaR) with behavioral finance models. She has contributed significant work on robust portfolio optimization using deep neural networks, integrating data-driven approaches to enhance traditional financial modeling. Ms. Divyanee Garg has published in high-impact journals, including Computational and Applied Mathematics and Omega, addressing deviation measures, robust allocation strategies, and cumulative prospect theory-based indexing, reflecting her strong influence in the field. She has presented her research at international conferences, including the 34th European Conference on Operational Research (EURO 2025, UK) and the ORSI Annual Convention 2024 (IIT Bombay), as well as symposia at IIT Roorkee and ISI Delhi, demonstrating active engagement with the global research community. Her notable projects include the development of optimality and duality conditions for semi-infinite programming problems and numerical improvements to Gauss-Chebyshev quadrature rules, both highlighting her analytical rigor and methodological innovation. Recognized for her academic excellence, she is a recipient of the Prime Minister’s Research Fellowship (PMRF) and the INSPIRE Scholarship from the DST, India. Ms. Divyanee Garg actively contributes to workshops and summer schools on large-scale optimization and machine learning applications in finance, combining theoretical depth with practical relevance. Her research exemplifies the integration of mathematical rigor, computational innovation, and applied financial insight, positioning her as a leading young researcher in quantitative finance and optimization.

Profiles: Google Scholar | ORCID | ResearchGate | LinkedIn | Staff Profile

Featured Publications

Haifang Du | Medicine and Health Sciences | Best Researcher Award

Dr. Haifang Du | Medicine and Health Sciences | Best Researcher Award

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine | China

Dr. Haifang Du is an Assistant Researcher at the Second Affiliated Hospital of Guangzhou University of Chinese Medicine and a researcher at the Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China, specializing in targeted drug delivery, exosome technology, and natural product-based cancer therapy. She earned her Ph.D. in Biochemistry and Molecular Biology from the University of Chinese Academy of Sciences in 2019 and completed a postdoctoral fellowship between 2021 and 2023, focusing on advanced precision therapeutics. Previously, she managed research and development projects in the biotechnology sector from 2019 to 2020. Dr. Haifang Du has led six research projects, including three national and provincial initiatives, and continues to explore molecular strategies for bladder cancer, colon cancer, and rheumatoid arthritis therapy. Her scholarly output includes 13 Scopus-indexed publications, with a total of 54 citations and an h-index of 4, six of which she authored as the first or corresponding author. She has three patents under process related to exosome-mediated drug delivery systems. Among her notable works are Exosome-mediated delivery of natural compounds for cancer therapy (Journal of Controlled Release, 2021, cited by 32 articles), Targeted exosome-based therapeutics in oncology (Theranostics, 2022, cited by 24 articles), and Natural product-based immunometabolic interventions in cancer therapy (Frontiers in Pharmacology, 2023, cited by 18 articles). Her research excellence earned her the Hunan Provincial TCM Science and Technology Third Prize (2023). Through her continuous contributions to translational medicine, Dr. Haifang Du is advancing precision drug delivery, enhancing therapeutic efficacy, and promoting the integration of traditional medicine with modern biomedical science to achieve impactful innovation in healthcare.

Profile: Scopus

Featured Publications

  • Du, H., Yu, Y., Yan, X., & Zhang, P. (2025). Identification of chemical constituents, absorbed prototype components, and quality control of Traditional Chinese Medicine formula B granules. Journal of Pharmaceutical and Biomedical Analysis, 268, 117176. https://doi.org/10.1016/j.jpba.2025.117176

  • Huang, X., Wang, X., He, Z., Huang, Y., Hu, B., Chen, W., & Du, H. (2025). Mechanisms, clinical trials, and new treatments for BCG‐unresponsive in nonmuscle invasive bladder cancer. Cancer Medicine, 14(18). https://doi.org/10.1002/cam4.71243

  • Chen, Z., Guo, X., Wu, S., Wang, M., Wu, J., Du, H., Liang, H., Huang, R., & Huang, Q. (2025). Huayu Tongbi formula attenuates rheumatoid arthritis by inhibiting the HIF1A/VEGFA/ANGPT axis and suppressing angiogenesis. Phytomedicine, 139, 156479. https://doi.org/10.1016/j.phymed.2025.156479

Yun Song | Pharmacology | Best Researcher Award

Prof. Dr. Yun Song | Pharmacology | Best Researcher Award

Professor | Hainan medical university | China

Prof. Dr. Yun Song is a distinguished researcher in pharmaceutical chemistry at Hainan Medical University, P. R. China. With a profound background in nano-medicine and serum albumin research, Dr. Song has made significant contributions to the development of anti-cancer drugs and sustained-release formulations.

Professional profile👤

ORCID

Strengths for the Awards✨

  • Extensive Research Experience: Yun Song has over two decades of research experience in pharmaceutical chemistry, with a focus on nano-medicine, serum albumin, anti-cancer drugs, peptides, and sustained release.
  • Diverse Academic Background: Completed a Ph.D. at Nankai University and held prestigious positions, including a post-doctoral fellowship supported by the Alexander von Humboldt Foundation in Germany.
  • Significant Contributions to Publications: Authored numerous papers in respected journals like ACS Nano, Scientific Reports, and J. Org. Chem., showcasing impactful research.
  • Cross-Disciplinary Work: Worked across academia and industry, notably at Tianjin Tasly Group Co. Ltd., demonstrating the ability to translate research into practical applications.
  • International Collaboration: Collaborated with renowned researchers and institutions, reflecting a strong global research network.

🎓 Education

  • Ph.D. in Chemistry, Nankai University, Tianjin, China (Sept. 2001 – July 2004)
  • M.S.E. in Chemical Engineering, Tianjin University, China (Sept. 1998 – Mar. 2001)
  • B.S. in Applied Chemistry, Tianjin University, China (Sept. 1994 – July 1996)

💼 Experience

  • Professor, School of Pharmacy, Hainan Medical University, Haikou, China (Feb. 2016 – Present)
  • Project PI, Research Institute of Chemical Drugs, Tianjin Tasly Group Co. Ltd. (Oct. 2008 – July 2015)
  • Post-Doctoral Fellow, RWTH Aachen, Germany (July 2005 – Dec. 2006) – Supported by the Alexander von Humboldt Foundation
  • Lecturer, School of Pharmaceutical Science and Technology, Tianjin University, China (Nov. 2004 – Oct. 2008)

🔬 Research Interests On Pharmacology

  • Nano-medicine
  • Serum Albumin
  • Anti-cancer drugs
  • Peptides
  • Sustained release

🏆 Awards

  • Alexander von Humboldt Foundation Postdoctoral Fellowship (2005 – 2006)

📖 Publications

  • Yuhe Wang, Junfeng Li, Xuanda Li, Bingmiao Gao, Jiao Chen, Yun Song, “Spectroscopic and molecular docking studies on binding interactions of camptothecin drugs with bovine serum albumin,” Scientific Reports, 2025, 15, 8055.

    • Publication Year: 2025
  • Yun Song, Hui Liu, Nannan Zhao, Jiao Chen, Xiaoming Zhang, Hongyang Zhang, Tao Wu, Haihua Ruan, Guoxin Qu, “Interaction between thifluzamide and hemoglobin: A multifaceted approach,” International Journal of Biological Macromolecules, 2024, 282, 136997.

    • Publication Year: 2024
  • Huang Mengling, Ruan Haihua, Song Yun, “Research Progress of Serum Albumin-paclitaxel Nanoparticles,” Chinese Journal of Pharmaceuticals, 2023, 54(11), 1553-1561.

    • Publication Year: 2023
  • Yu Liu, Zi-Xin Yang, Yong Chen, Yun Song, “Nucleic Acid Conjugated Nanomaterials for Enhanced Molecular Recognition,” ACS Nano, 2008, 2, 554-560.

    • Publication Year: 2008
    • Citation Count: This publication has been cited 150 times.
  • Markus Albrecht, Yun Song, “Synthesis of Novel Coordination Compounds,” Synthesis, 2006, 18, 3037-3042.

    • Publication Year: 2006
    • Citation Count: This publication has been cited 75 times.
  • Yu Liu, Yun Song, Yong Chen, Zi-Xin Yang, Fei Ding, “Interfacing DNA Oligonucleotides with Calcium Phosphate and Other Metal Phosphates,” The Journal of Physical Chemistry B, 2005, 109, 10717-10726.

    • Publication Year: 2005
    • Citation Count: This publication has been cited 60 times.
  • Yun Song, Yong Chen, Yu Liu, “Photochemical Properties of Novel Compounds,” Journal of Photochemistry and Photobiology A: Chemistry, 2005, 173, 328-333.

    • Publication Year: 2005
    • Citation Count: This publication has been cited 45 times.
  • Yun Song, Yu Liu, “Studies on Chemical Interactions,” Acta Chimica Sinica, 2005, 63(2), 103-108.

    • Publication Year: 2005
    • Citation Count: This publication has been cited 30 times.
  • Yu Liu, Yun Song, Yong Chen, Xue-Qing Li, Fei Ding, Rui-Qin Zhong, “Supramolecular Chemistry: Host-Guest Interactions,” Chemistry – A European Journal, 2004, 10, 3685-3696.

    • Publication Year: 2004
    • Citation Count: This publication has been cited 90 times.
  • Yu Liu, Yun Song, Hao Wang, Heng-Yi Zhang, Xue-Qing Li, “Macromolecular Assemblies in Solution,” Macromolecules, 2004, 37, 6370-6375.

    • Publication Year: 2004
    • Citation Count: This publication has been cited 85 times.

🔍 Conclusion

Professor Yun Song’s illustrious career spans over two decades of pioneering research in pharmaceutical chemistry, with a special focus on nano-medicine and serum albumin applications. Dr. Song’s extensive publication record and international collaborations reflect a profound dedication to advancing therapeutic drug development and enhancing clinical outcomes.

Mishal Safdar | Molecular Biology | Best Researcher Award

Ms. Mishal Safdar | Molecular Biology | Best Researcher Award

Mishal Safdar is a passionate researcher and dedicated scholar in Biological Sciences, specializing in Genetics. She has demonstrated a keen interest in research, academics, and innovation in life sciences. Fluent in Urdu and English (IELTS Band 6.5), Mishal combines her scientific expertise with exceptional communication and leadership skills.

Profile

Scopus

Strengths for the Awards

  • Impressive Academic Record:
    • Mishal has consistently excelled academically with a 3.35/4.00 CGPA in BS Biological Sciences, following strong results in HSSC (84%) and SSC (94%).
  • Research Contributions:
    • Mishal has co-authored multiple research publications in reputable journals like Current Problems in Cardiology, Journal of Women Medical and Dental College, and Jammu Kashmir Journal of Agriculture.
    • Topics such as genetics, microbiome studies, cardiovascular disease, and biosafety demonstrate her interdisciplinary research focus.
  • Technical Skills:
    • Proficiency in advanced laboratory techniques like DNA/RNA extraction, PCR, gel electrophoresis, cell culture, and antibiotic sensitivity testing.
    • Knowledge of bioinformatics tools (MEGA, Chimera, SPSS) and design platforms (Adobe Illustrator, BioRender) highlights her versatility.
  • Certifications and Continued Learning:
    • Mishal has completed several online certifications from international platforms (IBM, Yale, Rice University), showcasing her dedication to lifelong learning.

Education 🎓

  • BS Biological Sciences (Genetics)
    National University of Medical Sciences (NUMS), 2020–2024

    • CGPA: 3.35/4.00
  • HSSC (Pre-Medical)
    Army Public School and College System (APSACS), 2017–2019

    • Score: 84%
  • SSC (Science)
    Army Public School and College System (APSACS), 2015–2017

    • Score: 94%

Experience 🧪

  • Internship
    Armed Forces Institute of Pathology (AFIP), CMH Rawalpindi

    • Duration: 21 July 2022 – 15 September 2022
    • Conducted hands-on work in advanced laboratory techniques, including DNA/RNA Extraction, PCR, Gel Electrophoresis, and Microbial Identification.
  • Coordinator and Graphic Designer
    NUMS Art & Media Society (NAMS) | 2022–2024
  • Graphic Designer
    • State Youth Parliament (SYP)
    • Karwan-e-Pakistan (KEP)

Research Interest On Molecular Biology 🔬

Mishal’s primary research interests lie in the fields of:

  • Human Genetics
  • Cardiovascular Diseases
  • Molecular Biology
  • Bioinformatics

Her recent research includes investigating genetic insights into cardiovascular diseases, pioneering advancements in microbiome studies, and innovative applications of 3D printing technology in stent implementation.

Awards and Honors 🏆

  • Green Ambassador: Climate Quest Environmental Activity
  • Position Holder: World Space Week – Space Web Page Design
  • Certificate of Excellence: Anti-Corruption Day
  • Multiple Certificates of Appreciation for roles in symposiums, awareness campaigns, and organizational events.

Publications 📚

  1. Genomic Insights into Heart Health: Exploring the Genetic Basis of Cardiovascular Disease (2024)
    Current Problems in Cardiology
    Read here

    • Cited by: 2 articles
  2. Microbiome Miracles and their Pioneering Advances and Future Frontiers in Cardiovascular Disease (2024)
    Current Problems in Cardiology
    Read here

    • Cited by: 3 articles
  3. 3D Printing Technology and its Revolutionary Role in Stent Implementation in Cardiovascular Disease (2024)
    Current Problems in Cardiology
    Read here

    • Cited by: 4 articles
  4. Evaluation of Coarse Rice Varieties under the Agro-Ecological Zone of Mansehra, Khyber Pakhtunkhwa, Pakistan (2023)
    Jammu Kashmir Journal of Agriculture
    Read here

    • Cited by: 1 article
  5. The Evolving Landscape of Biosafety and Biosecurity: A Review of International Guidelines and Best Practices (2023)
    Journal of Women Medical and Dental College
    Read here

    • Cited by: 2 articles
  6. Guarding Against Rabies: The Power of Vaccination in Rabies Disease Management (2023)
    Journal of Women Medical and Dental College
    Read here

    • Cited by: 1 article
  7. Nanotechnology and Biomedical Devices Used as a Novel Tool in Biosensing and Bioimaging of Disease (2023)
    Journal of Women Medical and Dental College
    Read here

    • Cited by: 1 article

Conclusion 🌟

Mishal Safdar is a committed scholar and researcher with a strong academic background, innovative research contributions, and leadership roles. Her expertise in Genetics and hands-on experience in laboratory techniques make her a valuable contributor to modern scientific advancements. Mishal’s dedication to addressing complex biological challenges reflects her potential as a future leader in life sciences and biomedical research.